Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7051–7100 of 75467
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
each of Daniel Scavilla and Keith Pfeil, the directors of Merger Sub immediately prior to the Effective Time, became the directors of Nevro.
each of Daniel Scavilla and Keith Pfeil, the directors of Merger Sub immediately prior to the Effective Time, became the directors of Nevro.
On March 31, 2025, Eyal C. Attar, M.D., notified Vor Biopharma Inc. (the “Company”) of his decision to resign as Chief Medical Officer of the Company, effective as of April 18, 2025, in order to pursue a new opportunity.
On April 3, 2025, the Board of Directors of the Company appointed Rob Dolski, the Company’s current Chief Financial Officer, to serve as the principal accounting officer of the Company in addition to his current role as principal financial officer, effective immediately.
On February 24, 2025, Andrew Mercieca notified Autolus Therapeutics plc (the “Company”) of his intention to resign from his role as the Company’s Vice President of Finance and principal accounting officer, to pursue another opportunity.
pursuant to which Mr. Abuaita will transition from his current role to a new position as a Senior Advisor to the Company effective May 1, 2025
On March 31, 2025, Donna L. DeCarolis, President of National Fuel Gas Distribution Corporation, provided notice to National Fuel Gas Company of her intention to retire, effective July 1, 2025.
On March 31, 2025, the Board appointed Charles (“Chip”) Victor Bergh to the Board as a Class III director, effective as of April 1, 2025, with an initial term expiring at the Company’s 2025 annual meeting of stockholders.
On March 31, 2025, Beth Pritchard notified e.l.f. Beauty, Inc. (the “ Company ”) of her decision to resign from the Company’s Board of Directors (the “ Board ”) and all committees thereof, effective March 31, 2025.
Sumita Pandit, currently serving as Senior Executive Vice President, Chief Financial Officer of the Company, will become President and Chief Financial Officer of the Company upon Mr. Brummer’s retirement from his current role
On March 28, 2025, the Company and Mr. Brummer agreed to accelerate the date of Mr. Brummer’s retirement from his current role to April 21, 2025.
Robert E. Grove has agreed to resign and has submitted his resignation to the Company’s Board and all committees thereof, effective as of April 2, 2025.
On March 31, 2025, the Board, on the recommendation of the Corporate Governance and Nominating Committee, appointed John A. Fichthorn as a director, effective April 3, 2025
On April 3, 2025, the Board of Directors (the “Board”) of Quantum Corporation (the “Company”) appointed Lewis W. Moorehead, the Company’s Vice President of Finance and Treasurer, to serve as the Company’s Chief Financial Officer and Principal Financial Officer, effective as of April 4, 2025.
Mr. Moorehead succeeds Kenneth P. Gianella, who will be transitioning out of his current role as Chief Operating Officer, Chief Financial Officer and Principal Financial Officer, effective April 3, 2025
Effective April 2, 2025, Todd W. Arden, a member of the Board, informed the Company of his decision to resign from the Board.
On April 2, 2025, the Company appointed Karina Fedasz, 52, the Company’s Interim Chief Financial Officer, as Interim Chief Executive Officer of the Company, effective immediately.
Effective as of March 28, 2025, James Sapirstein resigned as Executive Chairman and a member of the Board of Directors (the “Board”) of Onconetix, Inc. (the “Company”).
Effective as of March 31, 2025, the Board of Directors (the “Board”) of the Company appointed Uri Levine, as a member and Chairman of the Board
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
Effective April 3, 2025, the Board of Directors (the “Board”) of FutureFuel Corp. (the “Company”) increased the size of the Board to nine members and the Company appointed Pamela R. Butcher as a Class C member of the Board until her successor is duly elected and qualified or until her earlier death, resignation or removal.
Matthew Edelman was appointed as Chief Executive Officer (“ CEO ”) of the Company, effective April 1, 2025
Effective April 1, 2025, the Company appointed Bant Breen as a Class I member of the Board of Directors of the Company
Effective March 31, 2025, Clark Callandar resigned as a Class I member of the Board of Directors of the Company.
Ann Hand, who was appointed Executive Chair effective April 1, 2025
the Company terminated, without cause, Karen Sims, M.D., Ph.D. as Chief Medical Officer of the Company, effective March 25, 2025.
the Company terminated, without cause, David Hastings as Chief Financial Officer of the Company, effective as of the end of the day on March 27, 2025.
On April 1, 2025, Robert Synowicki, Jr. confirmed to Knight-Swift Transportation Holdings Inc. (the "Company") that he will not be standing for reelection at the Company’s 2025 Annual Meeting of Stockholders.
HomeStreet and Mechanics Bank entered into a consulting agreement (the “ Consulting Agreement ”) with Mark Mason, the Chairman, Chief Executive Officer and President of HomeStreet, pursuant to which Mr. Mason’s employment with HomeStreet and HomeStreet Bank will terminate on the first day following the closing of the Merger
Thomas J. DeRosa, a member of the board of directors (the “Board”), Chair of the Compensation Committee and a member of the Audit Committee of Empire State Realty Trust, Inc. (the “Company”), notified the Company of his intention to retire and not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, currently expected to be held on May 15, 2025 (the “Annual Meeting”).
Effective April 2, 2025, the Board of Directors (the “Board”) of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Ron Philip, age 51, as a Class III director, filling the previously announced vacancy in the Board created by the resignation of Jack Bech Nielsen effective June 27, 2024.
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
appointed Carol DiBattiste, and Thomas D. Mitchell, to serve as independent members of the Board to fill the Board’s current vacancies, effective April 1, 2025
appointed Carol DiBattiste, and Thomas D. Mitchell, to serve as independent members of the Board to fill the Board’s current vacancies, effective April 1, 2025
On March 31, 2025, the board of directors (the “ Board ”) of FIGS, Inc. (the “ Company ”) appointed Jerry Jao to serve as a member of the Board, effective April 1, 2025 (the “ Effective Date ”).
On March 28, 2025, Alexander Baum notified the Board of Directors (the “Board”) of Insight Enterprises, Inc. (the “Company”) that he intends to retire from the Board and will not stand for election at the Company’s next annual meeting of stockholders (the “2025 Annual Meeting”).
On April 3, 2025, the Board of Directors of Patterson-UTI Energy, Inc. (the “Company”) approved the appointment of Forrest Robinson, 41, to the position of Chief Accounting Officer, effective immediately.
On March 31, 2025, Archer Aviation Inc. (the “Company”) announced the appointment of Harsh Rungta as its Senior Vice President, Finance and Chief Accounting Officer, effective immediately.
it has increased the size of the Company’s Board of Directors (the "Board") to 11 members and has appointed Robert A. DeMichiei to fill the newly created seat on the Board, effective April 2, 2025.
Following the appointment of Mr. Henn as an officer and director, Anthony Kerrigone resigned as an officer and director of the Company.
On March 31, 2025 Joseph C. Henn was appointed as a director, the Company’s Chief Executive, Financial and Accounting Officer and the Company’s Secretary.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.